Skip to main content

Table 1 Patient characteristics from which the 11 primary cancer cell lines were established

From: Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGFcchimeric protein targeting tissue factor

Cell line

Age (years)

Race

FIGO Stage

Grade

Histopathology

ADX-1 ARK-1

25

C*

IB

G3

Adenocarcinoma

ADX-2 ARK-2

33

C

IB

G3

Adenosquamous

ADX-3 ARK-3

33

AA**

IB

G3

Adenosquamous

ADX-4 ARK-4

46

C

IB

G2/G3

Adenocarcinoma

CVX-1 ARK-1

35

AA

IB

G3

Squamous

CVX-2 ARK-2

40

C

Recurrence

G3

Squamous

CVX-3 ARK-3

70

C

IB

G3

Squamous

CVX-4 ARK-4

40

C

IB

G3

Squamous

CVX-5 ARK-5

22

C

IB

G3

Squamous

CVX-6 ARK-6

29

C

IB

G3

Squamous

CVX-7 ARK-7

42

C

Recurrence

G3

Squamous

  1. ^FIGO, International Federation of Gynecology and Obstetrics
  2. *C, Caucasian;
  3. **AA, African-American